To further evaluate the in vivo effect of GABPA on ccRCC cells, we conducted tail vein and subcutaneous tumorigenic xenografts in nude mice by injecting 786-O cells transfected with GABPA (786-O/GABPA) and control (786-O/control) vectors, respectively. This evidence concerns the gene GABPA and nonpapillary renal cell carcinoma.